Fact.MR

Inhalable Biologics Market Risk Analysis by 2026

LogoEach year, millions of people are affected by respiratory diseases across the world, due to which, the use of inhalable biologics is also increasing. Inhalable biologics are agents that are formed from the products of living (plant or microorganisms) sources, which are used for treating chronic diseases and acute diseases such as asthma, COPD, and cystic fibrosis, among others. Inhalable biologics are beneficial over the conventional systems because of their target specific working. Inhaled and nasal delivery of biologic products are a more convenient method of administrating compounds systematically. Inhalable biologics used for long-term diseases give opportunity for the repurposing of existing products for inhaled and nasal delivery to boost patient experience, and help decrease complications. Inhalable biologics is the way of getting biological drugs specifically to the target by inhaling the drug. These inhalable biologics are sometimes synthesized through recombinant DNA technology, due to which, they work efficiently in the body and have various kinds of benefits accordingly. 

Holotomographic Imaging Market Opportunity by 2026

LogoHolotomographic imaging is a label-free laser technique of microscopy, which helps observe real-time imaging and the high-quality 3-D refractive index of living cells or tissues. It is widely used in cell biology laboratories for research purposes. Holotomographic imaging products provide high resolution with the help of low laser power that is faster than the normal microscope (in 2D and 3D). These products have a high impact and are cost-effective. Holotomographic imaging products use Optical Diffraction Tomography (ODT), which enables users to observe living cells and tissues. Holotomographic imaging products help in the early diagnosis of all the human infectious diseases. TomoStudio is a software used for the analysis of images on the screens of Holotomographic imaging devices. Holotomographic imaging devices measure the 3-D refractive index tomogram and 3-D fluorescence image of living cells or tissue samples. The key market players are focused on upgrading their products with the integration of advanced technology. These products are available in 3 forms, namely 2-dimensional, 3-dimensional and 4-dimensional image analysis, according their ability to analyse images. Some of the products are Tomocube HT 1, Tomocube HT2 and 3D CELL EXPLORER, among others. 

Waldenstrom Macroglobulinemia Market Demand Analysis by 2026

LogoWaldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few years, medical science has made progress and number of new treatments for Waldenstrom macroglobulinemia have been introduced. However, very few studies have been done to compare the best treatment. Hence, there is no single treatment available that works for all patients of Waldenstrom macroglobulinemia. Symptomatic Waldenstrom macroglobulinemia patients are kept under observation and do not receive any treatment until symptoms show up. Waldenstrom macroglobulinemia patients showing symptoms such as anemia, hyperviscosity, cold-agglutinin disease, amyloidosis, and peripheral neuropathy are considered for the treatment. Patients that show symptomatic hyperviscosity receive plasmapheresis along with rituximab treatment. In most of the cases of Waldenstrom macroglobulinemia, combination therapy with chemo and immunotherapy is recommended. Patients with Waldenstrom macroglobulinemia may require stem cell transplantation in the later stage. Hence, standard chemotherapy agents such as chlorambucil, bendamustine, cladribine, or fludarabine are not prescribed as a first line therapy as they may affect the stem cells. 

Anti-Reflective Glass Market Outlook Analysis by 2026

LogoAnti-Reflective Glass Market: Introduction

Occlusion Microcatheter Market Growth Analysis by 2026

LogoOcclusion Microcatheter is an innovative medical device which includes guidewire and catheters. Occlusion Microcatheter are inserted into the radial artery of arm of sometimes into the femoral artery of the leg to treat the curbed in the blood vessels. Curbing of blood vessel are cause due to the arteriosclerosis which results the deposition of lipid substances in blood vessels. Occlusion Microcatheter have thin wall surrounding which provided high tensile strength. Occlusion microcatheter is used for sealing when precise size and shape are required. The Microcatheter are of two types i.e. elastomeric microcatheter and occlusion microcatheter. Occlusion microcatheter is an advance version of micro catheter. Initially, occlusion microcatheter are is typically deep molded in a tubular shape and after the insertion in the artery it is then expanded to several times their original size.

Retinal Biosimilars Market Volume Analysis by 2026

LogoThe retinal biosimilars market has witnessed a remarkable boost with the approval of several retinal biosimilars in 2017. Amgen's Amgevita in March, f Biogen/Samsung Bioepis's Imraldi in August, and Boehringer Ingelheim Internationl's Cyltezo in November were approved in their respective regions. The slow adoption of retinal biosimilars is anticipated due to the initial reluctance of physicians to prescribe retinal biosimilars for individuals who have been using branded products over a long period of time. It is anticipated that retinal biosimilars, over the forecast period, could exploit their commercial potential due to the patent expiration of existing therapies such as Lucentis, Eyela, and others.

Ammonium Thiosulfate Market Pricing Analysis by 2026

LogoAmmonium Thiosulfate is an inorganic chemical compound majorly used in the making of liquid fertilizers. Ammonium Thiosulfate is produced by the reaction of elemental sulfur, aqueous ammonia and sulfur dioxide. The produced liquid of Ammonium Thiosulfate is highly soluble in water, and compatible with Nitrogen solutions and a number of other fluid fertilizers like NPK liquid blends. Ammonium Sulfate (ATS) consists of around 12% N and 26% S. Ammonium Thiosulfate acts as a source of sulfur and nitrogen for crops, which are required for better yields. Ammonium Thiosulfate is conventionally used in clear liquid blends and to some extent in suspensions. Ammonium Thiosulfate is mixed with a Urea Ammonium Nitrate solution commonly known as UAN solution for use as a fertilizer. Easy to handle and easy to mix, Ammonium Thiosulfate mixed with UAN can be applied by drip irrigation or sprinklers.

Early-Stage Lung Cancer Diagnostics Market Drivers Analysis by 2026

LogoApoptosis is a form of programmed cell death or cellular suicide. Apoptosis-susceptible cells are used in early-stage lung cancer diagnostics for the treatment of cytotoxic cancer. The agents of early-stage lung cancer diagnostics interact with the targeted cell to induce cell death. Early-stage lung cancer diagnostics has the ability to engage with the cancer cell. Early-stage lung cancer diagnostics works on the coupling phenomenon of drug-target interaction. The drug-target phenomenon of early-stage lung cancer diagnostics is the key factor behind the accuracy of the treatment. A few patients may show dramatic side-effects after undergoing cancer treatment with early-stage lung cancer diagnostics.

Rapid Industrialization to Boost AC Stabilized Power Supply Market Growth by 2018 to 2026

LogoFact.MR has announced the addition of the “ AC Stabilized Power Supply Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2026"report to their offering.

Amphibious Land Craft Market Competitive Landscape Analysis by 2026

LogoAmphibious Land Craft- Market Overview